Ypsomed saw the highest growth of 2.59% in patent filings in May and 2.49% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.24% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Ypsomed‘s patent filings and grants. Buy the databook here.
Ypsomed has been focused on protecting inventions in United States(US) with 18 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 67% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where Ypsomed is filings its patents. Among the top granted patent authorities, Ypsomed has 67% of its grants in United States(US), 22% in European Patent Office(EPO) and 11% in Australia(AU).
Becton Dickinson and Co and Amgen could be the strongest competitors for Ypsomed
In terms of grant share, Ypsomed stands in eighth position among its competitors. Becton Dickinson and Co and Amgen secured the top positions according to recent patent publication data.
Patents related to healthtech and remote patient monitoring lead Ypsomed's portfolio
Ypsomed has the highest number of patents in healthtech followed by, remote patient monitoring and connected care. For healthtech, nearly 29% of patents were filed and 29% of patents were granted in Q2 2024.
Drug delivery devices related patents lead Ypsomed portfolio followed by healthcare it, and other remote patient monitoring
Ypsomed has highest number of patents in drug delivery devices followed by healthcare it, other remote patient monitoring, hospital supplies, and wear & tear parts. For drug delivery devices, nearly 38% of patents were filed and 29% of patents were granted in Q2 2024.
For comprehensive analysis of Ypsomed's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.